TFS Capital’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-49,461
| Closed | -$92K | – | 849 |
|
|
2017
Q1 | $92K | Buy |
49,461
+5,839
| +13% | +$10.9K | 0.03% | 595 |
|
|
2016
Q4 | $226K | Buy |
+43,622
| New | +$226K | 0.06% | 484 |
|
|
2016
Q3 | – | Sell |
-47,802
| Closed | -$265K | – | 1107 |
|
|
2016
Q2 | $265K | Buy |
47,802
+32,139
| +205% | +$178K | 0.05% | 644 |
|
|
2016
Q1 | $69K | Buy |
+15,663
| New | +$69K | 0.01% | 932 |
|